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LAT Is Essential for FceRI-Mediated
Mast Cell Activation
antigen leads to activation of the Src-family protein tyro-
sine kinase (PTK) Lyn, which phosphorylates the tyro-
sines of the b and g ITAMs (Eiseman and Bolen, 1992;
Shinichiroh Saitoh,*# Ramachandran Arudchandran,²#
T. Scott Manetz,² Weiguo Zhang,*k
Connie L. Sommers,³ Paul E. Love,³
Juan Rivera,² and Lawrence E. Samelson*§ Yamashita et al., 1994). In this manner, activation creates
a new surface for the Syk PTK, which binds the phos-*Laboratory of Cellular and Molecular Biology
Division of Basic Science phorylated ITAM through its tandem SH2 domains. Inter-
action of Syk with the ITAMs also activates this enzyme.National Cancer Institute
²Section on Chemical Immunology Thus, the activated FceRI is characterized by associated
and active Syk PTK (Benhamou et al., 1993).National Institute of Arthritis and Musculoskeletal
and Skin Diseases The early events following activation of the FceRI ulti-
mately lead to the complex pattern of mast cell effector³Laboratory of Mammalian Genes and Development
National Institute of Child Health and Human function. Release of granules containing histamine, se-
rotonin, b-hexosaminidase, and mast cell±specific pro-Development
National Institutes of Health teases is a prominent feature. Transcription of multiple
cytokine and lymphokine genes and protein secretionBethesda, Maryland 20892
also follow receptor engagement. Among the cytokines,
interleukins 1±6, 9, 10, 13, 16, TNF-a, TGF-b, and GM-
CSF are known to be produced in activated mast cells
Summary (Metcalfe et al., 1997). A major question in the study
of FceRI-mediated signaling is how one of the earliest
The linker molecule LAT is a substrate of the tyrosine events following FceRI engagement, the activation of
kinases activated following TCR engagement of T PTKs, leads ultimately to granule release and gene tran-
cells. LAT is also expressed in platelets, NK, and mast scription (Benhamou et al., 1990). Activation of PTKs in
cells. Although LAT-deficient mice contain normal mast cells as in other systems leads to phosphorylation
numbers of mast cells, we found that LAT-deficient and activation of PLCg (Park et al., 1991). The resulting
mice were resistant to IgE-mediated passive systemic elevation of calcium is required for granule release and
anaphylaxis. LAT-deficient bone marrow±derived mast activation of such transcription factors as NF-AT. SLP-
cells (BMMC) showed normal growth and develop- 76, originally identified as a PTK substrate in T cells and
ment. Whereas tyrosine phosphorylation of FceRI, Syk, required for T cell development and activation, is also
and Vav was intact in LAT-deficient BMMCs following expressed in mast cells (Hendricks-Taylor et al., 1997;
FceRI engagement, tyrosine phosphorylation of SLP- Clements et al., 1998; Pivniouk et al., 1998; Yablonski
76, PLC-g1, and PLC-g2 and calcium mobilization et al., 1998). In mast cells prepared from mice genetically
were dramatically reduced. LAT-deficient BMMCs also engineered to be deficient in SLP-76, FceRI engagement
exhibited profound defects in activation of MAPK, fails to lead to b-hexosaminidase or IL-6 release in vitro.
degranulation, and cytokine production after FceRI Mice lacking SLP-76 are also resistant to IgE-mediated
cross-linking. These results show that LAT plays a passive anaphylaxis (Pivniouk et al., 1999).
critical role in FceRI-mediated signaling in mast cells. In T cells, SLP-76 and other critical signaling mole-
cules such as the Ras activator SOS are cytosolic pro-
teins. They constitutively bind the small linker mole-
Introduction cules, Grb2, and Grb2-related molecules such as Grap
and Gads. These linker molecules contain two SH3 do-
Extensive examination has revealed much about the mains surrounding an SH2 domain. The SH3 domains
structure and function of the mast cell high-affinity re- constitutively bind SLP-76 and SOS (Buday and Down-
ceptor for IgE, FceRI, the receptor central to mast cell ward, 1993; Egan et al., 1993; Feng et al., 1996; Liu et al.,
activation. As is true with many immunoreceptors, the 1999). Upon TCR engagement, these small complexes of
FceRI is comprised of multiple subunits, a ligand binding Grb2 and SLP-76 are brought to the plasma membrane
a chain, and two chains, b and g, which function as by an interaction of the Grb2 SH2 domain with phosphor-
signal transduction subunits (Blank et al., 1989; Alber ylated tyrosine residues of the integral membrane linker
et al., 1991). Both of these molecules contain an ITAM molecule LAT, which is heavily phosphorylated following
(immunoreceptor tyrosine-based activation motif), con- TCR activation. PLCg also docks on to LAT following
taining paired tyrosine residues (Reth, 1989). Engage- TCR engagement (Buday et al., 1994; Sieh et al., 1994;
ment of this receptor with IgE, followed by aggregation Weber et al., 1998; Zhang et al., 1998). Messenger RNA
of multiple IgE-bearing FceRI molecules by polyvalent encoding LAT is expressed in the mast cell line RBL-
2H3 (Zhang et al., 1998). It thus became important to
determine whether LAT is critical for mast cell function,
§ To whom correspondence should be addressed (e-mail: samelson@ as it is for T cells. To address this question, we derived
helix.nih.gov).
long-term mast cells by IL-3 stimulation of bone marrow# These authors contributed equally to this work.
cells isolated from LAT-deficient mice. Our results dem-kPresent address: Department of Immunology, Duke Medical Cen-
ter, Durham, NC 27710. onstrate a profound effect on mast cell function in cells
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Figure 1. LAT Protein Expression and Protein Tyrosine Phosphorylation of LAT Following FceRI Engagement in RBL-2H3 Cells and the Effect
of LAT on IgE-Mediated Passive Systemic Anaphylaxis
(A) Lysates from RBL-2H3 cells (5 3 106) were immunoprecipitated with preimmune serum (control) or anti-LAT antiserum, and then immunoblot-
ted with anti-LAT antiserum.
(B) RBL-2H3 cells (2 3 107) were sensitized in 10 ml media with anti-DNP IgE (1 mg/ml) for 12 hr and then stimulated with DNP-HSA (500 ng/
ml) or pervanadate (100 mM) for 2 min. Lysates from these cells were immunoprecipitated with anti-LAT antiserum. Immunoprecipitates were
fractionated by SDS-PAGE and proteins were transferred to nitrocellulose filters, which were probed with anti-phosphotyrosine antibody or
anti-LAT antiserum.
(C) Mice (n 5 5) were sensitized and challenged as described in Experimental Procedures. The data were analyzed for significance by a
unpaired t test. (a) Comparison of LAT1/1 in the presence (Ag1) or absence of antigen (Ag2) stimulation; p , 0.01. (b) Comparison of LAT1/1
to LAT2/2 in the presence of antigen (Ag1); p , 0.05.
isolated from these mice and show that LAT is critical those animals not receiving antigen showed no increase
in histamine levels over background (Figure 1C). Theseto normal mast cell function.
results do not reflect differences in the numbers of mast
cells found in these animals. Microscopic analysis dem-Results
onstrated that the number of skin mast cells detected
per field were approximately equal in wild-type (18.6 6To confirm that LAT protein is expressed in mast cells,
0), heterozygous (19.0 6 0.8), and LAT-deficient (18.8 6we first tested RBL cells for LAT expression and deter-
0.4) mice.mined whether LAT could be tyrosine phosphorylated
All subsequent analyses of mast cell LAT function infollowing FceRI engagement in these cells. Cells were
this study were performed on long-term mast cell linesincubated with monoclonal IgE specific for DNP, and
derived from bone marrow extracted from three popula-then the FceRI was aggregated by addition of multi-
tions: LAT-deficient mice (2/2), mice heterozygous forvalent DNP-HSA. After stimulation, postnuclear lysates
the targeted LAT gene (1/2) and wild-type animalswere subjected to immunoprecipitation with anti-LAT
(1/1). Bone marrow from these mice was cultured inantibodies. LAT protein was detected with the same
the presence of 20 ng/ml IL-3. Cell growth rates for allantibody by Western blot analysis, and the tyrosine
three populations were identical regardless of whetherphosphorylation of LAT was demonstrated by blotting
cells were counted after 2 or 7 weeks of culture in IL-3with anti-phosphotyrosine reagents (Figures 1A and 1B).
(data not shown). Similarly, the rates at which FceRI-As a test of the role of LAT for mast cell±mediated
positive cells expanded in these cultures were identicalcellular function in vivo, we compared normal and LAT-
in the three populations (data not shown). After 5 weeks,deficient mice for histamine release following engage-
cells were greater than 95% FceRI positive, as shownment of mast cell receptors. This assay, a test for passive
(Figure 2A). Cells from each of the three lines containedsystemic IgE-dependent anaphylaxis, is dependent on
equivalent numbers of toluidine-positive granules (datain vivo mast cell degranulation and histamine release.
not shown). To determine the amount of LAT protein,For this assay, mice were injected with monoclonal anti-
cells from the three lines were solubilized in detergent,DNP IgE and were subsequently challenged with either
and LAT protein was detected by blotting. No LAT pro-DNP-HSA or, as a control, with PBS. After 1.5 min, the
tein was detected in mast cells from the LAT2/2 mice.mice were euthanized and blood was obtained for the
An intermediate amount was found in mast cells fromassay. Five normal mice showed a massive increase in
systemic histamine, while the LAT-deficient mice and the heterozygous animals (Figure 2B).
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Figure 2. Surface IgE Receptor and LAT Ex-
pression Level in BMMCs from LAT1/1,
LAT1/2, and LAT2/2 Mice
(A) IgE receptor expression. Three popula-
tions of BMMCs (cultured for 5 weeks) were
treated with anti-DNP IgE mAb, and then in-
cubated with phycoerythrin-conjugated goat
anti-mouse Ig. Control staining was with phy-
coerythrin-conjugated goat anti-mouse Ig
alone.
(B) LAT expression level. Proteins in the ly-
sates from three populations of BMMCs (2 3
105 cell equivalents) were separated by SDS-
PAGE and LAT was detected by immu-
noblotting.
Cells from the mast cell lines were then stimulated of phosphorylated LAT, a 36±38 kDa protein, was easily
detected in the lysates of (2/2) cells (open arrowheads).through the FceRI and intracellular phosphorylation
events were evaluated. The earliest events occurring In addition, substrates with approximate apparent mo-
lecular weights of 76, 135, and 145 kDa (closed arrow-following receptor engagement are the phosphorylation
of receptor subunits and associated PTKs (Paolini et al., heads) were not observed in this lysate.
Known PTK substrates were then evaluated. SLP-76,1991; Eiseman and Bolen, 1992). Cell lines from the three
populations (1/1, 1/2, and 2/2) were stimulated by a PTK substrate in T and mast cells, is required for
optimal activation of both cell types (Hendricks-Taylorantigen activation. Immunoprecipitation of the b and g
chains of the receptor and analysis of the phosphotyro- et al., 1997; Yablonski et al., 1998; Pivniouk et al., 1999).
In T cells, it is brought to the plasma membrane by virtuesine content of these subunits is a test of the function
of the Src family PTK Lyn. No consistent difference in of its interaction with Gads, whose SH2 domain interacts
with phosphorylated LAT (Liu et al., 1999). Mast cellsthe level of phosphotyrosine or fold increase in phos-
photyrosine on these subunits was observed, (Figures from the LAT 1/1, 1/2, and 2/2 lines were activated
and SLP-76 was immunoprecipitated (Figure 4C). Equiv-3A and 3B, arrows indicate the b chains or multiple g
chain isoforms). In mast cell activation, the phosphoryla- alent levels of SLP-76 protein were detected in the three
populations. However, the level of tyrosine phosphoryla-tion of b and g chain ITAMs leads to recruitment and
activation of the Syk PTK. The level of Syk tyrosine tion on SLP-76 varied with the amount of LAT protein.
SLP-76 tyrosine phosphorylation was decreased in thephosphorylation serves as an indication of activation of
this enzyme. Following activation, there was no differ- heterozygous cells and was barely detectable in the cell
lines from the LAT2/2 mice. Vav, an activator of theence in the level of Syk tyrosine phosphorylation be-
tween the mast cells isolated from wild-type, heterozy- Rac family of G proteins, is another substrate of PTKs
activated in mast and T cells (Bustelo et al., 1992; Mar-gous, and LAT-deficient mice (Figure 3C).
In T cells, LAT functions downstream of the PTKs golis et al., 1992; Crespo et al., 1997). It coimmunopre-
cipitates with LAT in T cells activated via the TCR andactivated by the TCR, and thus the above results in mast
cells are not surprising. In normal FceRI-stimulated mast in mast cells after FceRI stimulation (Arudchandran et
al., 2000). This interaction is likely to be indirect andcells, LAT was isolated and its tyrosine phosphorylation
was detected by blotting with anti-phosphotyrosine an- mediated, in part, by Vav binding to SLP-76 (Tuosto et
al., 1996; Wu et al., 1996). In contrast to SLP-76, notibodies (Figure 4A). Phosphorylation was rapid and was
followed quickly by dephosphorylation. These kinetics significant difference in the level of Vav tyrosine phos-
phorylation was observed in the three cell lines (Fig-are similar to that seen with TCR engagement (Zhang et
al., 1998). LAT phosphorylation in T cells creates binding ure 4C).
Mast cells express two isoforms of phospholipasesites for signaling proteins containing SH2 domains and
allows these proteins to become phosphorylated and Cg (PLC) and both become phosphorylated on tyrosine
upon receptor engagement (Barker et al., 1998). The twoactivated at the plasma membrane. To test the effect of
LAT deficiency on the global level of intracellular tyrosine isoforms of PLC were isolated from LAT1/1, LAT1/2, and
LAT2/2 cell lines following activation. Rapid tyrosinephosphorylation, mast cells from wild-type and LAT2/2
mice were activated and the phosphotyrosine content phosphorylation of both isoforms was detected in all the
cells (Figure 4D). However, the level of phosphorylationof cellular lysates was compared (Figure 4B). The loss
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experiments, the mean peak calcium values in fluores-
cence ratio units from the three cell lines were: 1/1,
101.7 6 10.3; 1/2, 72.6 6 5.2; and 2/2, 56.2 6 4.5.
The response of all three cell lines to thapsigargin was
equivalent.
Receptor engagement also leads to activation of a
number of serine/threonine protein kinases of the mito-
gen-activated protein (MAP) family. ERK activation is
dependent on the Ras pathway (Hirasawa et al., 1995),
which is in turn activated by SOS, a protein bound to
LAT via the Grb2 linker molecule (Turner et al., 1995;
Finco et al., 1998). The activation of JNK is less well
characterized in hematopoietic cells. In mast cells, Vav
may be in part responsible via activation of SEK1, but
other pathways that involve the activation of PKC or the
activation of MKK7 are also implicated in JNK activation
(Teramoto et al., 1997; Kawakami et al., 1998; Song
et al., 1999). Both ERK2 and JNK1 were isolated by
immunoprecipitation from activated and nonactivated
mast cells from LAT1/1, LAT1/2, and LAT2/2 cell lines. In
vitro kinase assays were performed using myelin basic
protein and a c-Jun-GST chimeric protein as exogenous
substrates for the ERK2 (Figure 5B) and JNK1 assays
(Figure 5C), respectively. Enzyme activation was promi-
nent in the wild-type cells, intermediate in the heterozy-
gous, and barely detectable in the LAT2/2 cells.
Mast cell effector function was tested first by examin-
ing antigen-induced degranulation. The mast cell lines
were assayed for granule release of two mediators,Figure 3. Protein Tyrosine Phosphorylation of Syk and FceRI in
b-hexosaminidase (Figure 6A) and serotonin (Figure 6B).BMMCs Following Antigen Stimulation
For both assays, cells preloaded with IgE were in-Three populations of BMMCs were sensitized with anti-DNP IgE
and stimulated with DNP-HSA for 1 min as described in Experimental cubated with increasing amounts of antigen. Dose-
Procedures. Lysates from these cells were immunoprecipitated with response curves demonstrated a peak of degranulation
anti-FceR-b chain (A), anti-FceR±g chain (B), and anti-Syk (C). Immu- at a concentration of 10±100 ng/ml for all the cell lines
noprecipitated proteins were resolved on SDS-polyacrylamide gels, and for both mediators. However, as was observed in
transferred to nitrocellulose membrane filters, and then immunoblot-
the assays of the intracellular signaling pathways, theted with anti-phosphotyrosine antibody. After stripping, filters were
amount of mediator that was released depended on thereprobed with anti-FceR±b chain and anti-FceR±g chain to determine
amount of LAT. Activation of LAT-deficient cells resultedprotein levels. For Syk protein levels, the total lysate was immu-
noblotted. Arrows indicate FceR-b chain and anti-FceR±g chains. in only a low level of granule release, and the LAT1/2
Densitometric analysis of phosphorylated proteins was performed cells released an intermediate amount. All three cell lines
and the fold increase in intensity of the phosphoprotein from acti- released equal amounts of b-hexosaminidase in re-
vated cells compared to nonactivated cells is shown. These densito- sponse to 1 mM thapsigargin (Figure 6C).
metric values are normalized to protein levels.
Cytokine RNA levels were analyzed in LAT1/1, LAT1/2,
and LAT2/2 cells 1 hr after FceRI ligation using RT-PCR.
Unstimulated and stimulated populations of all three
varied with the level of LAT protein. Phosphorylation of cell lines contained equal amounts of D-glyceraldehyde
the enzyme in the heterozygous cells was at an interme- 3-phosphate dehydrogenase (GAPDH) transcripts, indi-
diate level and PLC phosphorylation in mast cells from cating appropriate normalization (Figure 7A). Five cyto-
the LAT2/2 mice was barely detectable. Tyrosine phos- kines and one chemokine were analyzed, and the re-
phorylation of PLCg isoforms is required for activation quirement for receptor ligation and LAT expression
of the enzyme leading to cleavage of phosphoinositides varied for each. For the chemokine MCP-1, transcripts
and the subsequent release of diacylglycerol and inosi- were present at a high level regardless of LAT expres-
tol phosphates (Nishibe et al., 1990). Elevation of inositol sion, and little effect of receptor ligation was observed.
phosphates leads to release of calcium from intracellular The generation of the other cytokines was markedly
stores and calcium influx from the extracellular space. inhibited in the LAT2/2 line. Receptor ligation in these
To test for activation-induced intracellular calcium ele- cells failed to result in generation of IL-2 or IL-3 message,
vation, the three cell lines were labeled with the calcium- and production of IL-6, IL-10, and TNF-a mRNA was
sensitive dyes Fluo-3 and Fura-Red, incubated with IgE, suppressed. A detailed kinetic analysis of IL-4 RNA lev-
and then activated with DNP-HSA (Figure 5A). Intracellu- els was also performed (Figure 7B). The response at 30
lar calcium levels were determined by calculating the min was similar, but over time, there was a marked
ratio of fluorescence intensity of Fluo-3 and Fura-Red. decrease in the amount of IL-4 message produced in
Cells from the LAT2/2 mice demonstrated a marked de- the 2/2 cells.
crease in intracellular calcium elevation, while the het- Direct analysis of cytokine protein confirmed and ex-
tended the conclusion that LAT is required for optimalerozygous cells showed an intermediate level. Over five
LAT Is Required for FceRI Activation of Mast Cells
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Figure 4. Protein Tyrosine Phosphorylation of LAT and Intracellular Signaling Molecules
(A) LAT1/1 BMMCs were sensitized with anti-DNP IgE and stimulated with DNP-HSA for the indicated time. For LAT phosphorylation, lysates
from LAT1/1 BMMCs were immunoprecipitated with anti-LAT antiserum and then immunoblotted with anti-phosphotyrosine antibody. After
stripping, the filter was reprobed with anti-LAT antiserum.
(B) Total cell lysates (2.5 3 105 cell equivalents) were prepared from LAT1/1 and LAT2/2 BMMCs sensitized with anti-DNP IgE and then
stimulated with DNP-HSA for the indicated time. Proteins were resolved on SDS-PAGE, transferred to nitrocellulose membrane filters, and
then immunoblotted with anti-phosphotyrosine antibody. Molecular weight (kilodaltons) markers are shown on the left. Arrowheads are defined
in the text.
(C and D) Three populations of BMMCs were sensitized with anti-DNP IgE and stimulated with DNP-HSA for 1 min or the indicated time.
Lysates from three populations of BMMCs were immunoprecipitated with anti-SLP-76 and anti-Vav (C) and anti-PLC-g1 and anti-PLC-g2 (D).
Immunoprecipitated proteins were resolved on SDS-PAGE, transferred to nitrocellulose membrane filters, and then immunoblotted with anti-
phosphotyrosine antibody. After stripping, the filters were reprobed with anti-SLP-76 and anti-Vav (C) and anti-PLC-g1 and anti-PLC-g2 (D)
to demonstrate the amount of protein. Densitometry was used to determine the indicated relative intensity levels as in Figure 3.
cytokine production and release (Figures 7C±7F). Levels of proximal PTK activation as demonstrated by b and
of four cytokine proteins (IL-2, IL-4, IL-6, and TNF-a) g chain and Syk tyrosine phosphorylation. Signaling ab-
reflected the amount of LAT protein in the cell. Differ- normalities were observed in pathways known to be
ences in the relative amounts of protein and RNA may downstream of PTK activation. Thus, SLP-76 and two
reflect differences in stimulation times between the isoforms of PLCg demonstrated a LAT-dependent de-
assays. crease in levels of phosphotyrosine following activation
of the FceRI. Phosphorylation was partially inhibited in
mast cells from heterozygous mice and was further de-Discussion
creased in cells from LAT2/2 mice. Decreased tyrosine
phosphorylation of PLCg correlates with a decrease inOur data demonstrate that LAT is central to FceRI-medi-
enzymatic activity, resulting in a decrease in IP3 andated signaling and effector function in mast cells, while
diacylglycerol production, which we measured indirectlynot having any obvious role in mast cell development.
as a decrease in calcium influx and MAP kinase activa-There was no difficulty growing mast cells from the bone
tion. There is some low level PLC activation in the LAT2/2marrow of LAT-deficient mice. The response to IL-3 was
cells, and this might account for the presence of theintact, and FceRI-bearing and functional cells were de-
minimal receptor-induced calcium elevation. The signifi-rived at the same rate from the marrow of LAT-deficient
cance of the lack of optimal SLP-76 tyrosine phosphory-and normal mice. Mast cell FceRI expression levels were
also normal. Receptor aggregation led to the same level lation is not as well understood. The Vav molecule, via
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Figure 5. Ca21 Mobilization and MAP Kinase Activities in LAT1/1, LAT1/2, and LAT2/2 BMMCs Following Antigen Stimulation
(A) BMMCs (2 3 106/ml) were loaded with Fluo-3 and Fura Red. BMMCs were sensitized with anti-DNP IgE (1 mg/ml) and then stimulated with
DNP-HSA (30 ng/ml) and thapsigargin (1 mM) at the indicated time. Fluo-3 and Fura Red fluorescence intensity after antigen stimulation was
measured by flow cytometry. Intracellular Ca21 concentrations were indicated by the ratio of Fluo-3/Fura Red fluorescence intensity.
(B and C) ERK and JNK activities in LAT1/1, LAT1/2, and LAT2/2 BMMCs following antigen stimulation. BMMCs were sensitized with anti-DNP IgE
and then stimulated with DNP-HSA. (B) ERK2 kinase activity was measured by in vitro kinase assay. The upper panel shows an autoradiograph of
32P incorporated into myelin basic protein (MBP) following its phosphorylation by ERK2 immunoprecipitates from BMMCs. The lower panel
shows the amount of ERK2 protein in the same cell lysates by anti-ERK2 immunoblot. (C) JNK1 kinase activity was measured by in vitro
kinase assay. The upper panel shows an autradiograph of 32P incorporated into c-Jun-GST following its phosphorylation by JNK1 immunoprecipi-
tates from BMMCs. The lower panel shows the amount of JNK1 found in the in vitro kinase reaction.
its SH2 domain, has been shown to bind tyrosine-phos- in the LAT2/2 cells. There was a good correlation be-
tween the decrease in message and protein for the vari-phorylated SLP-76 in T cells (Tuosto et al., 1996; Wu et
al., 1996). Though Vav tyrosine phosphorylation ap- ous cytokines.
The genetic approach to analyzing mast cell functionpeared normal in the LAT-deficient mast cells, a failure
of Vav and SLP-76 targeting to LAT in the plasma mem- has proved to be quite powerful. IL-3 driven cultures of
either fetal liver from mice deficient in Syk or bone mar-brane could impinge on the normal Vav function of small
G protein activation. This, in turn, has been demon- row from SLP-76-deficient mice have also been ana-
lyzed. Receptor engagement of Syk-deficient mast cellsstrated to contribute to a failure of complete JNK activa-
tion (Arudchandran et al., 2000). results in an absence of PLC phosphorylation and
calcium flux, Vav phosphorylation (unlike the LAT2/2Mast cell effector function was markedly impaired in
LAT-deficient cells. Secretion of two mediators, seroto- cells), ERK activation and degranulation. The defects
seem more absolute than those seen without LAT (Cos-nin and b-hexosaminidase, was partially inhibited in the
heterozygous cells and markedly impaired in the LAT2/2 tello et al., 1996). SLP-76-deficient mast cells seem more
like the LAT-deficient cells. There is a marked but notcells. It is notable that a low level of release of both
mediators was observed in these cells. This might also complete inhibition of PLC phosphorylation, calcium
flux, and granule release (Pivniouk et al., 1999). Thesereflect the low level of PLC activation and calcium re-
sponse discussed above. Production of mast cell cyto- studies of Syk and SLP-76 follow extensive biochemical
studies on Syk in mast cells and a few such studieskine message measured at 1 hr and cytokine protein
measured at 4 hr was partially to completely inhibited focusing on SLP-76 as a PTK substrate in these cells
LAT Is Required for FceRI Activation of Mast Cells
531
Figure 6. b-Hexosaminidase and Serotonin Release Following Antigen Stimulation of LAT1/1, LAT1/2, and LAT2/2 BMMCs
The extent of degranulation was determined by measuring the release of granular enzyme b-hexosaminidase or serotonin. BMMCs were
sensitized for 6 hr with anti-DNP IgE in medium (without IL-3) and then stimulated with the indicated concentration of DNP-HSA.
(A) Percent of b-hexosaminidase activity in supernatants versus total activity. Standard errors reflect four experiments.
(B) The percent release of incorporated [3H]serotonin. The results are reported as net release. Standard errors reflect three experiments.
(C) Cells were incubated with thapsigargin and b-hexosaminidase release was determined. Spontaneous release ranged from 3.9% to 5.2%.
(Oliver et al., 1994; Rivera and Brugge, 1995; Zhang et cell line show a complete block in signaling via the TCR
(Finco et al., 1998; Zhang et al., 1999a). The mast cellal., 1996; Hendricks-Taylor et al., 1997). The role of LAT
in mast cells had barely been addressed, since reagents defect defined in the current study is not as profound.
As with Lyn- and Syk-deficient mice, there appears toto study this molecule did not exist until recently. From
these studies and based on work in T cells, additional be no defect in mast cell development (Hibbs et al., 1995;
Costello et al., 1996). Mast cell activation is affected inwork on molecules that link enzymes and linker mole-
cules to LAT are likely to be productive. In particular, it a LAT concentration±dependent fashion. Most bio-
chemical pathways are not absolutely blocked in thehad been thought that Grb2 was the only linker bringing
most effector molecules to LAT in T cells (Finco et al., absence of LAT, though the defect is considerable. Of
interest is that the only in vivo response that we tested,1998; Zhang et al., 1998). The more recent identification
of Gads, a linker that couples SLP-76 to LAT in T cells, systemic anaphylaxis measured by serum histamine lev-
els, is completely blocked in the absence of LAT. Plate-suggests that this molecule and other Grb2-related
linkers need to be examined in mast cells (Feng et al., lets from the LAT-deficient mice show a block in signal-
ing via the GPVI receptor (Pasquet et al., 1999). This1996; Bourette et al., 1998; Liu and McGlade, 1998; Qiu
et al., 1998; Liu et al., 1999). molecule is associated with Syk and PLC activation and
calcium release. Calcium flux in the LAT-deficient plate-The LAT molecule is expressed in four cell types: T,
mast, NK cells, and platelets (Zhang et al., 1998; lets does not occur in response to the appropriate pep-
tide ligand, though other signaling pathways mediatedFacchetti et al., 1999). Studies with cells isolated from
the LAT-deficient mice indicate that the significance and by, for example, thrombin receptor are intact. Finally,
NK cells seem to be the least affected of the four popula-function of LAT varies in the four cell types. The loss of
LAT affects the T cell lineage most dramatically. There tions. NK numbers and function appear normal, at least
on a population level (Zhang et al., 1999b). It should beis a complete block in T cell development in mice homo-
zygous for the LAT deletion (Zhang et al., 1999b). Inter- noted that in one study, some NK clones were partially
blocked by overexpression of dominant-negative LATestingly, one copy of the LAT gene is sufficient for nor-
mal intrathymic development. The role of LAT in normal protein, suggesting a role for LAT in certain NK cells
(Jevremovic et al., 1999). The overall impression fromT cell function cannot be easily addressed, but two inde-
pendently derived LAT-deficient variants of the Jurkat this ongoing work is that the four cell types rely on LAT
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Figure 7. Expression of Cytokine mRNAs and Secretion of Cytokines Following Antigen Stimulation of LAT1/1, LAT1/2, and LAT2/2 BMMCs
(A and B) BMMCs were sensitized with anti-DNP IgE and stimulated with DNP-HSA as described in Experimental Procedures. mRNA was
purified from these BMMCs and cytokine mRNAs were detected by RT-PCR using specific primers for each cytokine.
(C±F) Secretion of cytokine following antigen stimulation from LAT1/1, LAT1/2, and LAT2/2 BMMCs. Cytokine levels were measured by ELISA.
Flow Cytometric Analysis of IgE Receptor Expressionas a central linker molecule to varying degrees. Where
Cells (1 3 106/ml) were stained for FceRI expression with 2.5 mg/dependence on LAT is not complete, other mechanisms
ml anti-DNP IgE (SPE-7 mAb, Sigma), followed by phycoerythrin-for bringing signaling molecules to the surface are likely
conjugated goat anti-mouse Ig (Southern Biotechnology) and ana-
to be found. lyzed by flow cytometry using a FACScan (Becton Dickinson) (Cos-
tello et al., 1996).
Experimental Procedures
Passive Systemic Anaphylaxis
Mice were sensitized for 24 hr with 2 mg of anti-DNP IgE (Liu et al.,Mice
1980) by intravenous injection. They were subsequently challengedGeneration of LAT-deficient mice was reported in detail by Zhang
by intravenous injection of 500 mg of DNP-HSA (Sigma) for 1.5 min,et al. (1999b). Mice were caged in a specific pathogen-free environ-
euthanized with CO2, and blood was immediately collected by car-ment in accordance with National Institutes of Health regulations.
diac puncture. Serum histamine concentration was determined us-All mice were of a C57BL/6 and 129/Sv mixed background.
ing a competitive histamine immunoassay kit (Immunotech).
Immunoblotting and ImmunoprecipitationSkin Mast Cell Determination
Cells (2±5 3 107 in 10 ml) were preloaded for at least 4 hr with anti-Naive animals were sacrificed and an area of shaved dorsal skin
DNP IgE (1 mg/ml) in medium (without IL-3). Cells were challengedwas removed and fixed in 10% formalin. Slides were made and
in Tyrode's buffer (10 mM HEPES buffer [pH 7.4], 130 mM NaCl, 5stained with toluidine blue. The number of blue staining mast cells
mM KCl, 1.4 mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, and 0.1%were counted in the epidermis and dermis using three fields for each
BSA) with DNP-HSA (100 ng/ml). Cell lysates for immunoblottingslide at 2003 magnification. Cell counts did not vary significantly
were prepared by direct boiling in reducing sample buffer and werebetween animals, and thus values were averaged.
separated on a 12% acrylamide gel. Prior to immunoprecipitation,
cells were usually lysed in buffer containing 1% Brij, 150 mM NaCl,
50 mM Tris-HCl (pH 7.6), PMSF, pepstatin, aprotinin, leupeptin, so-Mast Cell Isolation
Bone marrow cells taken from LAT1/1, LAT1/2, and LAT2/2 mouse dium orthovanadate, and EDTA for 30 min on ice. The detergents
used for SLP-76 immunoprecipitation were 1% Triton X-100, 1%femurs were incubated in suspension cultures with IL-3 for 4 to
8 weeks. IgE receptor expression level was determined by flow octylglucoside, and 0.1% SDS. Detergents used to immunoprecipi-
tate FceRI-g chain were 0.5% Triton X-100 and 1% octylglucoside.cytometry.
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Antibodies used for immunoprecipitation were anti-LAT antiserum and the aqueous layer containing RNA was extracted with chloro-
form. The RNA was then precipitated with isopropanol. First strand(Zhang et al., 1998), anti-Syk (a gift of U. Blank, Institut Pasteur),
anti-FceRI-b chain (Rivera et al., 1988), anti-FceRI-g chain (a gift cDNA synthesis was carried out using the Life Technologies Super-
script RT-PCR kit. Three to five mg of total RNA was used in reactionsof R. P. Siraganian, NIH), anti-PLC-g1 and anti-SLP-76 (Upstate
Biotechnology), anti-PLC-g2 and anti-Vav (Santa Cruz Biotechnol- primed with oligo dT to obtain cDNA. Then 1±5 ml of the synthesized
c-DNA was used as the template for the cytokine mRNA amplifica-ogy). Antibodies used for immunoblotting were 4G10 and anti-Vav
(Upstate Biotechnology), anti-Syk (a gift of P. Draber, Institute of tion reactions. Primers for amplification of various cytokines were
obtained from Clontech and Biosource. All cytokines were assayedMolecular Genetics, Prague), anti-FceRI-b chain, and anti-FceRI-g
chain (Moriya et al., 1997). Immunoprecipitations and immunoblot- with two distinct sets of primers to insure that the obtained product
did not result from genomic DNA contamination.ting were carried out by standard procedures. Reagents used for
detection of antibody in immunoblots were donkey-anti-rabbit IgG-
horseradish peroxidase (HRP) and sheep-anti-mouse IgG-HRP (Am-
Detection of Cytokines
ersham), anti-chicken IgG-HRP (Jackson Immunoreseach Labora-
For detection of IL-6, cells (5 3 106 /ml) were incubated with 1 mg/
tories), and Protein A/Protein G-HRP (Pierce).
ml of anti-DNP IgE for 3 hr and stimulated for 24 hr with 30 ng/ml
of DNP-HSA. Supernatant was collected and secreted IL-6 was
Measurement of Calcium Flux determined using a murine specific IL-6 ELISA detection kit (Endo-
Cells (2 3 106/ml) were incubated with 16 mM Fluo-3-AM and 16 mM gen). For detection of IL-2, IL-4, and TNF-a, cells (4 3 107) were
Fura Red in Tyrode's buffer at 37oC for 45 min. Cells were preloaded incubated in 15 ml media with 1 mg/ml of anti-DNP IgE for 14 hr
with anti-DNP IgE (1mg/ml) on ice for 1 hr and then kept at room and subsequently stimulated for 4 hr with 30ng/ml of DNP-HSA.
temperature for 30 min to allow cleavage of the AM esters. The After stimulation, the media (15 ml) was recovered and concentrated
cells were washed twice with Tyrode's buffer and analyzed by flow approximately 50-fold by using Ultrafree-15 Biomax-5 (Millipore). In
cytometry. Intracellular Ca21 concentration was indicated by Fluo- some experiments, cell pellets were lysed to quantitate the level of
3/Fura Red fluorescence intensity ratios. intracellular cytokines. Cytokine levels were determined by ELISA
as above.
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